AC Immune (ACIU) Non-Current Assets (2014 - 2026)
AC Immune (ACIU) recorded Non-Current Assets of $72.12 million in the quarter ended Jun 30, 2026, up 2.2% from $70.56 million a year earlier but down 1.6% from the prior quarter.
Powered by 
Analysis
AC Immune (ACIU) Non-Current Assets (2014 - 2026) Analysis & Trends
As of Dec 31, 2025, AC Immune reported Non-Current Assets of $69.39 million, up 3.6% from the prior year.
- Annual Non-Current Assets has increased for three straight years, with a five-year compound annual growth rate of 56.3% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Non-Current Assets came in at $66.97 million in the year ended Dec 31, 2024 (+4.3%), $64.2 million in the year ended Dec 31, 2023 (+5.9%), $60.64 million in the year ended Dec 31, 2022 (-5.8%) and $64.36 million in the year ended Dec 31, 2021 (+765.6%).
- Quarterly Non-Current Assets has ranged from $8.73 million in the quarter ended Sep 30, 2021 to $73.26 million in the quarter ended Mar 31, 2026 over the past five years.
- On a year-over-year basis, Non-Current Assets has increased for five consecutive quarters, with growth averaging 6.0% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 726.9% in the quarter ended Dec 31, 2021, against a decline of 5.9% in the quarter ended Dec 31, 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $73.26 million (quarter ended Mar 31, 2026), $71.98 million (quarter ended Dec 31, 2025) and $72.33 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | AC Immune | 265.55 Mn | 265.55 Mn | - | 72.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.12 Mn |
| Mar 31, 2026 | 73.26 Mn |
| Dec 31, 2025 | 71.98 Mn |
| Sep 30, 2025 | 72.33 Mn |
| Jun 30, 2025 | 70.56 Mn |
| Mar 31, 2025 | 65.56 Mn |
| Dec 31, 2024 | 67.26 Mn |
| Sep 30, 2024 | 65.40 Mn |
| Jun 30, 2024 | 63.02 Mn |
| Mar 31, 2024 | 65.77 Mn |
| Dec 31, 2023 | 65.00 Mn |
| Sep 30, 2023 | 64.31 Mn |
| Jun 30, 2023 | 63.48 Mn |
| Mar 31, 2023 | 62.13 Mn |
| Dec 31, 2022 | 60.04 Mn |
| Sep 30, 2022 | 60.01 Mn |
| Jun 30, 2022 | 60.64 Mn |
| Mar 31, 2022 | 63.30 Mn |
| Dec 31, 2021 | 63.78 Mn |
| Sep 30, 2021 | 8.73 Mn |
API Access
AC Immune Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();